Trial Profile
An Open Randomised 4-Way Crossover Single Dose And A Parallel Group Multiple Dose Comparative Pharmacokinetic Study Of The PF-04191834 Phase 2 Tablet And The Phase 1 Dispersion Formulations.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs PF 4191834 (Primary)
- Indications Asthma; Pain
- Focus Pharmacokinetics
- Sponsors Pfizer
- 19 Feb 2010 New trial record